{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,15]],"date-time":"2025-02-15T05:17:45Z","timestamp":1739596665861,"version":"3.37.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T00:00:00Z","timestamp":1739491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T00:00:00Z","timestamp":1739491200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Addict Sci Clin Pract"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The availability of the fellowships of Alcoholics Anonymous and Narcotics Anonymous in community settings is extensive and patients admitted to treatment programs for substance use disorder may therefore have previously attended meetings of these two Twelve Step (TS) programs. Data on such prior attendance and related clinical findings, however, are not typically available. They can, however, be relevant to how ensuing treatment is planned. We therefore undertook this study to ascertain the feasibility of evaluating how the level of TS attendance prior to treatment entry can be evaluated, and to determine clinically relevant findings that are associated with such attendance.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Over the course of 2022, 3,125 patients were admitted to a large urban multimodal United States-based treatment center. All patients were administered the structured interview-based Global Appraisal of Individual Needs upon admission. This instrument is employed to evaluate substance use, demographics, and related psychosocial variables. Clinically related variables were analyzed relative to whether given respondents have a history of any TS group attendance prior to admission.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Distinctions were found between the 57.3% of respondents who had previously attended any TS meetings and the 42.6% who had not attended any meetings. Compared to respondents who had never attended TS meetings, those who had ever attended scored higher on emotional problems (<jats:italic>p<\/jats:italic>\u2009&lt;.001, d = -0.58), and had more likely undergone previous SUD treatment (<jats:italic>p<\/jats:italic>\u2009&lt;.001, d\u2009=\u20090.80). They were less likely to use substances in unsafe situations (<jats:italic>p<\/jats:italic> &lt;.001, d = -0.55) and were less likely to express reluctance to remain abstinent (<jats:italic>p<\/jats:italic>\u2009&lt;.001, d = -0.50). The 11% of respondents who considered themselves regular TS members reported a lower frequency of recent substance use (<jats:italic>p<\/jats:italic>\u2009&lt;.001, d = -0.80) and were more likely to have attended intensive outpatient (<jats:italic>p<\/jats:italic>\u2009&lt;.001, 0.46) and residential (<jats:italic>p<\/jats:italic>\u2009&lt;.001, 0.44) treatment than patients who did not consider themselves regular attenders.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Examination of TS attendance prior to treatment admission is feasible. Findings can be clinically relevant for differential treatment planning and can also serve as a basis for further research into the role of TS participation in community settings.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13722-025-00542-5","type":"journal-article","created":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T05:40:51Z","timestamp":1739511651000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Patient characteristics associated with their level of twelve-step attendance prior to entry into treatment for substance use disorders"],"prefix":"10.1186","volume":"20","author":[{"given":"Marc","family":"Galanter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William L.","family":"White","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael L.","family":"Dennis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brooke","family":"Hunter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lora","family":"Passetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Lustig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,14]]},"reference":[{"key":"542_CR1","doi-asserted-by":"publisher","first-page":"107232","DOI":"10.1016\/j.addbeh.2021.107232","volume":"128","author":"AH Hai","year":"2022","unstructured":"Hai AH, Oh S, Lee CS, Kelly JF, Vaughn MG, Salas-Wright CP. Mutual-help group participation for substance use problems in the US: correlates and trends from 2002 to 2018. Addict Behav. 2022;128:107232.","journal-title":"Addict Behav"},{"issue":"1","key":"542_CR2","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1111\/j.1360-0443.2007.02050.x","volume":"103","author":"M Gossop","year":"2008","unstructured":"Gossop M, Stewart D, Marsden J. Attendance at Narcotics Anonymous and alcoholics Anonymous meetings, frequency of attendance and substance use outcomes after residential treatment for drug dependence: a 5-year follow-up study. Addiction. 2008;103(1):119\u201325.","journal-title":"Addiction"},{"issue":"14","key":"542_CR3","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1080\/10826084.2022.2136496","volume":"57","author":"C Mutschler","year":"2022","unstructured":"Mutschler C, Haines H, Gryspeerdt C, Bushe J, McShane K, Lochran M, et al. Integration of twelve step with evidence-based practices in a residential treatment center. Subst Use Misuse. 2022;57(14):2110\u20136.","journal-title":"Subst Use Misuse"},{"issue":"1","key":"542_CR4","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1080\/08897077.2012.691452","volume":"34","author":"SE Zemore","year":"2013","unstructured":"Zemore SE, Subbaraman M, Tonigan JS. Involvement in 12-step activities and treatment outcomes. Subst Abus. 2013;34(1):60\u20139.","journal-title":"Subst Abus"},{"issue":"7","key":"542_CR5","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1111\/j.1530-0277.2011.01727.x","volume":"36","author":"JF Kelly","year":"2012","unstructured":"Kelly JF, Urbanoski K. Youth recovery contexts: the incremental effects of 12-step attendance and involvement on adolescent outpatient outcomes. Alcohol Clin Exp Res. 2012;36(7):1219\u201329.","journal-title":"Alcohol Clin Exp Res"},{"issue":"2","key":"542_CR6","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1111\/j.1360-0443.2011.03570.x","volume":"107","author":"J Witbrodt","year":"2012","unstructured":"Witbrodt J, Kaskutas LA, Bond J, Delucchi K. Does sponsorship improve outcomes above alcoholics Anonymous attendance? A latent class growth curve analysis. Addiction. 2012;107(2):301\u201311.","journal-title":"Addiction"},{"issue":"1\u20133","key":"542_CR7","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.drugalcdep.2010.12.008","volume":"116","author":"MS Subbaraman","year":"2011","unstructured":"Subbaraman MS, Kaskutas LA, Zemore S. Sponsorship and service as mediators of the effects of making alcoholics Anonymous Easier (MAAEZ), a 12-step facilitation intervention. Drug Alcohol Depend. 2011;116(1\u20133):117\u201324.","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"542_CR8","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1080\/07347324.2019.1613942","volume":"38","author":"AJ O\u2019Sickey","year":"2020","unstructured":"O\u2019Sickey AJ, Hanes J, Tonigan JS. The relationship between perceived alcoholics Anonymous social group dynamics and getting an AA sponsor. Alcohol Treat Q. 2020;38(1):21\u201331.","journal-title":"Alcohol Treat Q"},{"key":"542_CR9","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.drugalcdep.2016.02.028","volume":"162","author":"JF Kelly","year":"2016","unstructured":"Kelly JF, Greene MC, Bergman BG. Recovery benefits of the therapeutic alliance among 12-step mutual-help organization attendees and their sponsors. Drug Alcohol Depend. 2016;162:64\u201371.","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"542_CR10","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1097\/ADM.0000000000001108","volume":"17","author":"JW Welsh","year":"2023","unstructured":"Welsh JW, Sitar SI, Dennis ML. Utility of the Global Appraisal of Individual needs recommendation and Referral Report for Substance Use diagnosis, Treatment Planning, and Placement. J Addict Med. 2023;17(3):353\u20135.","journal-title":"J Addict Med"},{"key":"542_CR11","unstructured":"Haymarket Center. Impact. Haymarket Center. Accessed January 29. 2024. https:\/\/hcenter.org\/impact\/"},{"key":"542_CR12","unstructured":"Dennis ML et al. (2008). Global Appraisal of Individual Needs (GAIN): Administration guide for the GAIN and related measures. Bloomington, IL. Retrieved from www.gaincc.org\/gaini"},{"key":"542_CR13","doi-asserted-by":"publisher","first-page":"108414","DOI":"10.1016\/j.jsat.2021.108414","volume":"126","author":"ML Dennis","year":"2021","unstructured":"Dennis ML, Davis JP. Screening for more with less: validation of the Global Appraisal of Individual needs quick v3 (GAIN-Q3) screeners. J Subst Abuse Treat. 2021;126:108414.","journal-title":"J Subst Abuse Treat"},{"issue":"4","key":"542_CR14","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1177\/0193841X15599645","volume":"39","author":"KM Conrad","year":"2015","unstructured":"Conrad KM, Conrad KJ, Passetti LL, Funk RR, Dennis ML. Validation of the full and short-form self-help involvement scale against the Rasch Measurement Model. Eval Rev. 2015;39(4):395\u2013427. https:\/\/doi.org\/10.1177\/0193841X15599645.","journal-title":"Eval Rev"},{"issue":"7","key":"542_CR15","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1016\/j.addbeh.2013.02.013","volume":"38","author":"C Kenaszchuk","year":"2013","unstructured":"Kenaszchuk C, Wild TC, Rush BR, Urbanoski K. Rasch model of the GAIN Substance Problem Scale among Canadian adults seeking residential and outpatient addiction treatment. Addict Behav. 2013;38(7):2279\u201387.","journal-title":"Addict Behav"},{"issue":"3","key":"542_CR16","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s11121-022-01448-3","volume":"24","author":"B Bray","year":"2023","unstructured":"Bray B, Layland EK, Stull SW, Vasilenko SA, Lanza ST. Estimating the effects of a complex, multidimensional moderator: an example of latent class moderation to examine differential intervention effects of substance use services. Prev Sci. 2023;24(3):493\u2013504.","journal-title":"Prev Sci"},{"key":"542_CR17","doi-asserted-by":"publisher","first-page":"2410","DOI":"10.4236\/psych.2017.814152","volume":"8","author":"IA Kira","year":"2017","unstructured":"Kira IA, Shuwiekh H, Kucharska J. Screening for psychopathology using the three factors model of the structure of psychopathology: a modified form of GAIN short screener. Psychology. 2017;8:2410\u201327.","journal-title":"Psychology"},{"issue":"1","key":"542_CR18","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1037\/0033-2909.112.1.155","volume":"112","author":"J Cohen","year":"1992","unstructured":"Cohen J. A power primer. Psychol Bull. 1992;112(1):155\u20139. https:\/\/doi.org\/10.1037\/\/0033-2909.112.1.155.","journal-title":"Psychol Bull"},{"key":"542_CR19","volume-title":"National Survey of Substance Abuse Treatment Services (N-SSATS): 2020. Data on substance abuse treatment facilities","author":"Substance Abuse and Mental Health Services Administration","year":"2021","unstructured":"Substance Abuse and Mental Health Services Administration. National Survey of Substance Abuse Treatment Services (N-SSATS): 2020. Data on substance abuse treatment facilities. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2021."},{"key":"542_CR20","doi-asserted-by":"publisher","first-page":"104316","DOI":"10.1016\/j.ijmedinf.2020.104136","volume":"139","author":"D Morel","year":"2020","unstructured":"Morel D, Yu KC, Liu-Ferraro A, Liu-Ferrara A, Caceres-Suriel AJ, Kurtz SG, Tabak YP. Predicting hospital readmission in patients with mental or substance use disorders: a machine learning approach. Int J Med Inf. 2020;139:104316.","journal-title":"Int J Med Inf"},{"key":"542_CR21","unstructured":"Alcoholics Anonymous General Service Office. Estimates of A.A. Groups and Members as of December 31, 2021. Published January 2022. Accessed January 30. 2024. https:\/\/www.aa.org\/sites\/default\/files\/literature\/SMF-53%20EstimatesofAAGroupsandMembers%20EN%200122.pdf"},{"key":"542_CR22","unstructured":"Narcotics Anonymous World Services. Meeting Map. Published August 2. 2023. Accessed January 30, 2024. https:\/\/worldna.org\/wp-content\/uploads\/2023\/08\/world-regional-map_081223.pdf"},{"issue":"3","key":"542_CR23","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.psc.2022.05.008","volume":"45","author":"DR Gastfriend","year":"2022","unstructured":"Gastfriend DR, Mee-Lee D. Thirty years of the ASAM Criteria: a report card. Psychiatr Clin North Am. 2022;45(3):593\u2013609.","journal-title":"Psychiatr Clin North Am"},{"key":"542_CR24","doi-asserted-by":"publisher","first-page":"22","DOI":"10.15288\/jsads.2019.s18.22","volume":"18","author":"A Ritter","year":"2019","unstructured":"Ritter A, Mellor R, Chalmers J, Sunderland M, Lancaster K. Key considerations in planning for substance use treatment: estimating treatment need and demand. J Stud Alcohol Drugs. 2019;18:22\u201330.","journal-title":"J Stud Alcohol Drugs"},{"key":"542_CR25","doi-asserted-by":"crossref","unstructured":"Rush B, Tremblay J, Brown D. Development of a needs-based planning model to estimate required capacity of a substance use treatment system. J Stud Alcohol Drugs Suppl 2019;Sup 18;51\u201363.","DOI":"10.15288\/jsads.2019.s18.51"},{"key":"542_CR26","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.jsat.2018.05.002","volume":"91","author":"JP Davis","year":"2018","unstructured":"Davis JP, Berry D, Dumas TM, Ritter E, Smith DC, Menard C. Substance use outcomes for mindfulness-based relapse prevention are partially mediated by reductions in stress: results from a randomized trial. J Subst Abuse Treat. 2018;91:37\u201348.","journal-title":"J Subst Abuse Treat"},{"issue":"2","key":"542_CR27","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1080\/13811118.2022.2066591","volume":"27","author":"MJ Fleury","year":"2023","unstructured":"Fleury MJ, Grenier G, Cao Z, Huynh C, Chihade D. Predictors of emergency department use for suicidal behaviors among patients with substance-related disorders. Arch Suicide Res. 2023;27(2):796\u2013817.","journal-title":"Arch Suicide Res"},{"issue":"4","key":"542_CR28","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1177\/0093854817737806","volume":"45","author":"JL Wilson","year":"2018","unstructured":"Wilson JL, Bandyopadhyay S, Yang H, Cerulli C, Morse DS. Identifying predictors of substance use and recidivism outcome trajectories among drug treatment court clients. Crim Justice Behav. 2018;45(4):447\u201367.","journal-title":"Crim Justice Behav"},{"issue":"4","key":"542_CR29","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1097\/JAN.0000000000000310","volume":"30","author":"HG Claro","year":"2019","unstructured":"Claro HG, Oliveira MAF, Fernandes IFAL, Boska GDA, Santos ND, Pinho PH, et al. Analysis of the Global Appraisal of Individual needs in the City of Sao Paulo. J Addict Nurs. 2019;30(4):269\u201375.","journal-title":"J Addict Nurs"},{"issue":"3","key":"542_CR30","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1055\/s-2004-830100","volume":"73","author":"M Bottlender","year":"2005","unstructured":"Bottlender M, Soyka M. Catamnestic study on the efficacy of an intensive outpatient treatment programme for alcohol-dependent patients: impact of participation in AA on abstinence rates. Fortschr Neurol Psychiatr. 2005;73(3):150\u20135.","journal-title":"Fortschr Neurol Psychiatr"},{"issue":"6","key":"542_CR31","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1111\/j.1360-0443.2009.02524.x","volume":"104","author":"FW Chi","year":"2009","unstructured":"Chi FW, Kaskutas LA, Sterling S, Campbell CI, Weisner C. Twelve-step affiliation and 3- year substance use outcomes among adolescents: social support and religious service attendance as potential mediators. Addiction. 2009;104(6):927\u201339.","journal-title":"Addiction"},{"issue":"6","key":"542_CR32","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1002\/jclp.20259","volume":"62","author":"RH Moos","year":"2006","unstructured":"Moos RH, Moos BS. Participation in treatment and alcoholics Anonymous: a 16-year follow-up of initially untreated individuals. J Clin Psychol. 2006;62(6):735\u201350.","journal-title":"J Clin Psychol"},{"issue":"3","key":"542_CR33","first-page":"CD012880","volume":"3","author":"JF Kelly","year":"2020","unstructured":"Kelly JF, Humphreys K, Ferri M. Alcoholics Anonymous and other 12-step programs for alcohol use disorder. Cochrane Database Syst Rev. 2020;3(3):CD012880.","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"542_CR34","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1080\/10826084.2017.1325904","volume":"53","author":"RP Wiebe","year":"2018","unstructured":"Wiebe RP, Griffin AM, Zheng Y, Harris KS, Cleveland HH. Twelve step, two factors: coping strategies moderate the association between craving and daily 12-Step use in a college recovery community. Subst Use Misuse. 2018;53(1):114\u201327.","journal-title":"Subst Use Misuse"},{"issue":"2","key":"542_CR35","doi-asserted-by":"publisher","first-page":"18m12292","DOI":"10.4088\/JCP.18m12292","volume":"80","author":"RD Weiss","year":"2019","unstructured":"Weiss RD, Griffin ML, Marcovitz DE, Hilton BT, Fitzmaurice GM, McHugh RK, et al. Correlates of opioid abstinence in a 42-month posttreatment naturalistic follow-up study of prescription opioid dependence. J Clin Psychiatry. 2019;80(2):18m12292.","journal-title":"J Clin Psychiatry"}],"container-title":["Addiction Science &amp; Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13722-025-00542-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13722-025-00542-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13722-025-00542-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T17:15:09Z","timestamp":1739553309000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascpjournal.biomedcentral.com\/articles\/10.1186\/s13722-025-00542-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,14]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["542"],"URL":"https:\/\/doi.org\/10.1186\/s13722-025-00542-5","relation":{},"ISSN":["1940-0640"],"issn-type":[{"type":"electronic","value":"1940-0640"}],"subject":[],"published":{"date-parts":[[2025,2,14]]},"assertion":[{"value":"3 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This project was approved by the Institutional Review Board of the Chestnut Health System. The survey data were anonymized without items that would allow for obtaining respondents\u2019 respective identities. The datasets used and\/or analyzed during the current study are available from the corresponding author upon reasonable request. Certain individual items from the GAIN subsumed under substance and mental health scales and indices are listed in Table\u00a01. Tables\u00a02 and 3 include measures whose effect sizes (Cohen\u2019s h or d) are 0.20 or greater (minimum cut- point for a small effect). Analyses were conducted using SPSS Statistics Version 29.0.2.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16"}}